Mankind Pharma Reschedules Q2 & H1 FY27 Earnings Conference Call to 26th Oct'26
Mankind Pharma Ltd 路 Intimation 路 22 Oct 2026, 9:09 pm
Mankind Pharma Reschedules Q2 & H1 FY27 Earnings Conference Call to 26th Oct'26 Mankind Pharma Limited has rescheduled its Earnings Conference Call for Q2 & H1 FY27 to Monday, 26th Oct'26, at 05:00 PM IST, advancing it from the earlier scheduled time of 06:00 PM IST on the same date. The company confirmed that all other previously communicated details regarding the earnings call remain unchanged.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA 路 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference 路 06 Nov 2026
- Please find attached intimation regarding ESG Rating 路 05 Nov 2026
- Intimation of participation in the Investor Conference. 路 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 路 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL 路 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet 路 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 路 27 Oct 2026
